The American Medical Association (AMA) has adopted two new marijuana-related resolutions—one that advocates for a ban on flavored cannabis vaping products and another that recognizes the risks and potential therapeutic benefits of use among older adults.
AMA’s House of Delegates last month approved both measures—the latest in a line of drug policy-related resolutions the body has advanced in recent years that oppose commercial marijuana legalization while backing expungement of cannabis records and supporting broad drug decriminalization, among stances on other issues.
The newly adopted measure on marijuana use by older people simultaneously notes that there is a “higher incidence of dementia among individuals who use cannabis” but also that “cannabis may offer therapeutic benefits for managing agitation in dementia patients, potentially serving as an alternative to antipsychotic medications.”
“Greater transparency regarding both the potential benefits and adverse effects of cannabis use in older adults would be valuable to physicians, particularly given the current paucity of research that is focused on this population,” it says.
As such the measure maintains that:
“RESOLVED, that our American Medical Association support the development and publication of educational resources on medical cannabis directed towards clinicians, including a virtual educational presentation that reviews the known effects
Read full article on Marijuana Moment
